Thirteen Years' Experience of Pharmacokinetic Monitoring and Dosing of Busulfan: Can the Strategy be Improved?

@article{Buffery2014ThirteenYE,
  title={Thirteen Years' Experience of Pharmacokinetic Monitoring and Dosing of Busulfan: Can the Strategy be Improved?},
  author={Pamela J Buffery and Kirstie M Allen and P. Chin and G. Moore and M. Barclay and E. Begg},
  journal={Therapeutic Drug Monitoring},
  year={2014},
  volume={36},
  pages={86–92}
}
  • Pamela J Buffery, Kirstie M Allen, +3 authors E. Begg
  • Published 2014
  • Medicine
  • Therapeutic Drug Monitoring
  • Background: A busulfan concentration monitoring and dosing service has been provided by Christchurch Hospital since 1998. This study aimed to see (1) the percentage of patients with an area under the concentration time curve (AUC) outside the target range and had dose adjustment, (2) how busulfan clearance (CL) relates to body weight, and (3) if fewer samples could be used to predict doses. Methods: Blood samples were taken from patients after oral administration, usually at 0.5, 1, 1.5, and 6… CONTINUE READING

    Topics from this paper.

    Performance of Busulfan Dosing Guidelines for Pediatric Hematopoietic Stem Cell Transplant Conditioning.
    • 25
    • Highly Influenced

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 19 REFERENCES
    Plasma concentration monitoring of busulfan: does it improve clinical outcome?
    • 91